Citadel Advisors’s Acorda Therapeutics ACOR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Hold |
|
|||||
2023
Q1 | – | Hold |
|
|||||
2022
Q4 | – | Hold |
|
|||||
2022
Q3 | – | Hold |
|
|||||
2022
Q2 | – | Hold |
|
|||||
2022
Q1 | – | Sell |
|
|||||
2021
Q4 | $35K | Buy |
|
|||||
2021
Q3 | – | Sell |
|
|||||
2021
Q2 | $213K | Buy |
|
|||||
2021
Q1 | – | Hold |
|
|||||
2020
Q4 | – | Sell |
|
|||||
2020
Q3 | $68K | Buy |
|
|||||
2020
Q2 | $12K | Sell |
|
|||||
2020
Q1 | $97K | Buy |
|
|||||
2019
Q4 | $118K | Buy |
|
|||||
2019
Q3 | – | Sell |
|
|||||
2019
Q2 | $2.91M | Buy |
|
|||||
2019
Q1 | $4.93M | Buy |
|
|||||
2018
Q4 | $4.14M | Buy |
|
|||||
2018
Q3 | – | Hold |
|
|||||
2018
Q2 | – | Hold |
|
|||||
2018
Q1 | – | Hold |
|
|||||
2017
Q4 | – | Sell |
|
|||||
2017
Q3 | $310K | Sell |
|
|||||
2017
Q2 | $18.5M | Buy |
|
|||||
2017
Q1 | $6.8M | Buy |
|
|||||
2016
Q4 | $737K | Sell |
|
|||||
2016
Q3 | $12.2M | Buy |
|
|||||
2016
Q2 | $3.15M | Buy |
|
|||||
2016
Q1 | $649K | Buy |
|
|||||
2015
Q4 | $158K | Sell |
|
|||||
2015
Q3 | $450K | Buy |
|
|||||
2015
Q2 | – | Sell |
|
|||||
2015
Q1 | $638K | Buy |
|
|||||
2014
Q4 | $586K | Sell |
|
|||||
2014
Q3 | $3.56M | Sell |
|
|||||
2014
Q2 | $26.2M | Buy |
|
|||||
2014
Q1 | $8.06M | Sell |
|
|||||
2013
Q4 | $8.83M | Buy |
|
|||||
2013
Q3 | $3.49M | Buy |
|
|||||
2013
Q2 | $1.7M | Buy |
|